In this video, Paolo Caimi, MD, a physician and clinical investigator at Cleveland Clinic, discussed research on the use of ...
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...
Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...
A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...
Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
Basel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) ...
An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received 510(k) clearance from the United States Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback